Bharathwaj Ramakrishnan analyses this potential loophole that allows the bypassing of Section 3(d) by framing the claim as to be looked at under Section 3(e) instead. (3/3)
#patent #IPO #grant #section3d #PreGrant #opposition #cancer #SpicyIP
spicyip.com/2024/12/form...
0
0
0
0